Is BiondVax Pharmaceuticals (BVXV) stock Moving In The Right Direction?

It is a common theme among investors to look into stocks that may have recorded handsome gains over the course of a few weeks and such a course of action is perfectly understandable.

If you are in the hunt for such a stock, then you could take a look at the BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV) stock, which has managed to deliver gains of as much as 8% over the course of the past month. There has been no recent news about the company but back in May, BiondVax had announced its financial results for the fourth quarter and also for the full year that concluded on December 31 last year.

The company, which is involved in the development and commercialisation of products meant for preventing as well as treating infectious diseases, ran up total expenses of NIS (New Israeli Shekels) 12.3 million for the quarter. It was considerably lower than the figure of NIS 45.7 million in the year ago period.

The total expenses for the year came in at NIS 68.2 million but it was neutralised by way of other incomes totalling NIS 78.3 million. Research and development expenses for the year came in at NIS 51.4 million, which was lower than NIS 68.6 million in the 2019 financial year.  

Market Reaction:

On Friday, BVXVstock jumped by 1.3% to $3.12 with more 5kshares, compared to  its average volume of 128k shares. The stock has moved within a range of $3.0000 – 3.1400after opening the trade at $3.10. Over the past 52-week, the stock has been trading within a range of $2.3500 – 62.0000.

Related Posts

About The Author